• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

齐-韦二氏综合征肝移植术后亚急性神经病:一例报告

Subacute Neuropathy Post-Liver Transplantation in Zellweger Spectrum Disorder: A Case Report.

作者信息

Gonzalez Clarissa, Cohen Madelyn J, Hong Juhee, Calame Daniel, Marri Kavitha, Harpavat Sanjiv, Wangler Michael F, Mysore Krupa

机构信息

School of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, USA.

出版信息

Am J Med Genet A. 2025 Apr;197(4):e63941. doi: 10.1002/ajmg.a.63941. Epub 2024 Dec 5.

DOI:10.1002/ajmg.a.63941
PMID:39632697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11885015/
Abstract

Peroxisome biogenesis disorders-Zellweger spectrum disorder (PBD-ZSD) is a rare genetic disease caused by mutations in the genes involved in peroxisome biogenesis. PBD-ZSD presentations vary in severity, and treatment of PBD-ZSD remains supportive focused on specific complications. A few reported cases of the use of liver transplantation to treat either neurological symptoms or liver dysfunction and cirrhosis in PBD-ZSD have been published. In this case report, we document the course of a 16-year-old boy diagnosed with PBD-ZSD and a delayed and unexpected neuropathy that developed after undergoing orthotopic liver transplantation (OLT) for which the indication was liver cirrhosis. Following OLT, the patient's gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), alanine transaminase (ALT), and albumin normalized; however, he developed a polyneuropathy, the cause of which was investigated with conditions such as inflammatory neuropathies (Guillain Barré syndrome: GBS/chronic inflammatory demyelinating polyneuropathy: CIDP), drug effect, or underlying complication of PBD-ZSD all considered possible. His neuropathic symptoms improved and therefore this case represents an exploration of an apparent delayed and resolving subacute neuropathy in PBD-ZSD after OLT.

摘要

过氧化物酶体生物发生障碍-泽尔韦格谱系障碍(PBD-ZSD)是一种由参与过氧化物酶体生物发生的基因突变引起的罕见遗传病。PBD-ZSD的临床表现严重程度各异,其治疗仍以针对特定并发症的支持治疗为主。已有少数关于使用肝移植治疗PBD-ZSD的神经症状或肝功能障碍及肝硬化的报道病例。在本病例报告中,我们记录了一名16岁男孩的病程,他被诊断为PBD-ZSD,并在因肝硬化接受原位肝移植(OLT)后出现了延迟且意外的神经病变。OLT后,患者的γ-谷氨酰转移酶(GGT)、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和白蛋白恢复正常;然而,他出现了多发性神经病变,对其病因进行了调查,考虑了诸如炎性神经病变(吉兰-巴雷综合征:GBS/慢性炎性脱髓鞘性多发性神经病变:CIDP)、药物作用或PBD-ZSD的潜在并发症等可能情况。他的神经病变症状有所改善,因此本病例代表了对PBD-ZSD患者OLT后出现的明显延迟且可缓解的亚急性神经病变的一次探索。

相似文献

1
Subacute Neuropathy Post-Liver Transplantation in Zellweger Spectrum Disorder: A Case Report.齐-韦二氏综合征肝移植术后亚急性神经病:一例报告
Am J Med Genet A. 2025 Apr;197(4):e63941. doi: 10.1002/ajmg.a.63941. Epub 2024 Dec 5.
2
Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype.具有轻微 Zellweger 谱系障碍表型患者的诊断挑战和疾病管理。
Mol Genet Metab. 2021 Nov;134(3):217-222. doi: 10.1016/j.ymgme.2021.09.007. Epub 2021 Sep 27.
3
A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers.Zellweger 谱障碍的代谢组学图谱揭示了新的疾病生物标志物。
Genet Med. 2018 Oct;20(10):1274-1283. doi: 10.1038/gim.2017.262. Epub 2018 Feb 8.
4
A Retrospective Study of Hearing Loss in Patients Diagnosed with Peroxisome Biogenesis Disorders in the Zellweger Spectrum.对 Zellweger 谱中诊断为过氧化物酶体生物发生障碍的患者的听力损失的回顾性研究。
Ear Hear. 2022 Mar/Apr;43(2):582-591. doi: 10.1097/AUD.0000000000001126.
5
Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.泽尔韦格综合征疾病:从严重的新生儿疾病到非典型的成人表现。
Adv Exp Med Biol. 2020;1299:71-80. doi: 10.1007/978-3-030-60204-8_6.
6
Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.过氧化物酶体生物发生障碍的泽尔韦格谱系:当前诊断、临床表现及治疗指南概述
Mol Genet Metab. 2016 Mar;117(3):313-21. doi: 10.1016/j.ymgme.2015.12.009. Epub 2015 Dec 23.
7
Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder.Pex1-G844D NMRI 小鼠模型的纵向研究:一种用于轻度 Zellweger 谱系障碍的强大临床前模型。
Biochim Biophys Acta Mol Basis Dis. 2020 Nov 1;1866(11):165900. doi: 10.1016/j.bbadis.2020.165900. Epub 2020 Jul 18.
8
Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.齐-韦二氏综合征谱系障碍的诱导多能干细胞模型显示过氧化物酶体组装受损和细胞类型特异性脂质异常。
Stem Cell Res Ther. 2015 Aug 29;6:158. doi: 10.1186/s13287-015-0149-3.
9
Two novel mutations of in one Chinese Zellweger spectrum disorder and their clinical characteristics.一名中国泽尔韦格谱系障碍患者中[基因名称]的两个新突变及其临床特征 。 需注意,原文中“Two novel mutations of in one Chinese Zellweger spectrum disorder”这里“of”后面缺少具体基因名称等关键信息,翻译时补充了[基因名称]以便完整表意。
Ann Transl Med. 2019 Aug;7(16):368. doi: 10.21037/atm.2019.06.42.
10
Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder.13 名 Zellweger 谱疾病患者的肝脏症状和组织学表现。
J Inherit Metab Dis. 2019 Sep;42(5):955-965. doi: 10.1002/jimd.12132. Epub 2019 Jul 30.

本文引用的文献

1
Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype.具有轻微 Zellweger 谱系障碍表型患者的诊断挑战和疾病管理。
Mol Genet Metab. 2021 Nov;134(3):217-222. doi: 10.1016/j.ymgme.2021.09.007. Epub 2021 Sep 27.
2
Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder.13 名 Zellweger 谱疾病患者的肝脏症状和组织学表现。
J Inherit Metab Dis. 2019 Sep;42(5):955-965. doi: 10.1002/jimd.12132. Epub 2019 Jul 30.
3
Nerve conduction normal values for electrodiagnosis in pediatric patients.神经传导正常数值在儿科患者电诊断中的应用。
Muscle Nerve. 2019 Aug;60(2):155-160. doi: 10.1002/mus.26499. Epub 2019 May 11.
4
Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders.泽尔韦格谱系障碍的长期胆酸治疗
Case Rep Gastroenterol. 2018 Jun 28;12(2):360-372. doi: 10.1159/000490095. eCollection 2018 May-Aug.
5
Inborn Errors of Metabolism Involving Complex Molecules: Lysosomal and Peroxisomal Storage Diseases.涉及复杂分子的先天性代谢缺陷:溶酶体和过氧化物酶体贮积症。
Pediatr Clin North Am. 2018 Apr;65(2):353-373. doi: 10.1016/j.pcl.2017.11.011.
6
Living-donor liver transplantation for mild Zellweger spectrum disorder: Up to 17 years follow-up.轻度泽尔韦格谱系障碍的活体肝移植:长达17年的随访
Pediatr Transplant. 2018 May;22(3):e13112. doi: 10.1111/petr.13112. Epub 2018 Feb 16.
7
Development and validation of a severity scoring system for Zellweger spectrum disorders.Zellweger 谱障碍严重程度评分系统的建立与验证。
Clin Genet. 2018 Mar;93(3):613-621. doi: 10.1111/cge.13130. Epub 2017 Dec 1.
8
Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders.口服胆酸对胆汁酸合成及泽尔韦格谱系障碍患者有效且耐受性良好。
J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):321-326. doi: 10.1097/MPG.0000000000001657.
9
Cholic acid therapy in Zellweger spectrum disorders.胆汁酸疗法治疗泽尔韦格谱系障碍。
J Inherit Metab Dis. 2016 Nov;39(6):859-868. doi: 10.1007/s10545-016-9962-9. Epub 2016 Jul 28.
10
Living-Donor Liver Transplantation From a Heterozygous Parent for Infantile Refsum Disease.来自杂合子父母的活体肝移植治疗婴儿型Refsum病
Pediatrics. 2016 Jun;137(6). doi: 10.1542/peds.2015-3102.